alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 17.86 Provision of hospital care and medical services during certain disasters and emergencies under 38 U.S.C. 1785. ( a ) This section sets forth regulations regarding the provision of hospital care and medical services under 38 U.S.C. 1785.
( b ) During and immediately following a disaster or emergency referred to in paragraph (c) of this section, VA under 38 U.S.C. 1785 may furnish hospital care and medical services to individuals (including those who otherwise do not have VA eligibility for such care and services) responding to, involved in, or otherwise affected by that disaster or emergency.
( c ) For purposes of this section, a *disaster* or *emergency* means: ( 1 ) A major disaster or emergency declared by the President under the Robert T. Stafford Disaster Relief and Emergency Assistance Act (42 U.S.C. 5121 *et seq.*) (Stafford Act); or
( 2 ) A disaster or emergency in which the National Disaster Medical System established pursuant to section 2811(b) of the Public Health Service Act (42 U.S.C. 300hh-11(b)) is activated either by the Secretary of Health and Human Services under paragraph (3)(A) of that section or as otherwise authorized by law.
( d ) For purposes of paragraph (b) of this section, the terms *hospital care* and *medical services* have the meanings given such terms by 38 U.S.C. 1701(5) and 1701(6).
( e ) The cost of care for medical care and services provided under this section will be determined in accordance with the following: ( 1 ) If the care is provided to an officer or employee of a non-VA Federal agency VA will charge the rate agreed upon by the Secretary and the head of such department or agency or the Secretary concerned. If no such rate has been agreed to, VA will charge the Inter-Agency Rate as prescribed in § 17.102(c).
( 2 ) If the care is provided to a member of the Armed Forces VA will charge the rate agreed upon by the Secretary and the head of such branch or the Secretary concerned. If no such rate has been agreed to, VA will charge the Inter-Agency Rate as prescribed in § 17.102(c).
( 3 ) If the care is authorized under a sharing agreement as described in 38 U.S.C. 8111 or 8153 or § 17.240, VA will charge the rate determined in accordance with the sharing agreement.
( 4 ) If the care is provided to an individual who is responsible for the cost of the care, VA will charge the Cost-Based Rate as prescribed in § 17.102(c). Individuals will be responsible for the cost of care or services if mandated by Federal law (including applicable Appropriations Acts) or when the cost of care or services is not reimbursed by other-than-VA Federal departments or agencies.
( f ) VA may furnish care and services under this section to a veteran without regard to whether that individual is enrolled in the VA healthcare system under 38 U.S.C. 1705 and § 17.36 of this part.
[73 FR 26946, May 12, 2008, as amended at 88 FR 32975, May 23, 2023]
#### § 42.25 Fees.

The party requesting a subpoena shall pay the cost of the fees and mileage of any witnesses subpoenaed in the amounts that would be payable to a witness in a proceeding in United States District Court. A check for witness fees and mileage shall accompany the subpoena when served, except that when a subpoena is issued on behalf of the Department of Veterans Affairs, a check for witness fees and mileage need not accompany the subpoena.
###### Editorial Note on Part 1

#### Editorial Notes:

1. In Patent and Trademark Office publications and usage the part number is omitted from the numbers of §§ 1.1 to 1.352 and the numbers to the right of the decimal point correspond with the respective rule numbers.

2. For nomenclature changes to part 1, see 68 FR 14335, Mar. 25, 2003; 87 FR 68904, Nov. 17, 2022.

#### § 1.174 [Reserved]

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 2 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 6 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 7 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 1 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 3 pertaining to both patents and trademarks is placed in the grouping pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 4 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 5 is placed in the separate grouping of parts pertaining to patents regulations.
# Official Journal C 327/2019

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 327 |
| | |
| English edition | Information and Notices | Volume 6230 September 2019 |

ISSN 1977-091X

Official Journal

of the European Union

C 327

English edition

Information and Notices

Volume 6230 September 2019

---

| Contents | page |
| --- | --- |
| | IV   Notices |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2019/C 327/01 | Communication from the Commission to the European Parliament, the Council and the Court of Auditors Consolidated annual accounts of the European Union for the financial year 2018 | 1 |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| 2019/C 327/02 | The Court’s statement of assurance provided to the European Parliament and the Council — Independent auditor’s report | 168 |

Contents

page

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2019/C 327/01

Communication from the Commission to the European Parliament, the Council and the Court of Auditors Consolidated annual accounts of the European Union for the financial year 2018

Consolidated annual accounts of the European Union for the financial year 2018

1

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

2019/C 327/02

The Court’s statement of assurance provided to the European Parliament and the Council — Independent auditor’s report

168

---

| EN | |
| --- | --- |

EN
# L_2009012EN.01S00301.xml

| 16.1.2009 | EN | Official Journal of the European Union | L 12/s3 |
| --- | --- | --- | --- |

16.1.2009

EN

Official Journal of the European Union

L 12/s3

---

NOTE TO THE READER

The institutions have decided to no longer quote in their texts the last amendment to cited acts.

Unless otherwise indicated, references to acts in the texts published here are to the version of those acts currently in force.

---
**Exhibit 32.2**

**CERTIFICATIONPURSUANT TO18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection withthe Quarterly Report of CKX, Inc. (the “Company”) on Form 10-Qfor the quarter ended September 30, 2006 as filed with the Securities andExchange Commission on the date hereof (the “Report”), I, Thomas P. Benson,Executive Vice President and Chief Financial Officer of the Company, certify,pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-OxleyAct of 2002, that:

(1)   The Reportfully complies with the requirements of section 13(a) or 15(d) of theSecurities Exchange Act of 1934; and

(2)   Theinformation contained in the Report fairly presents, in all material respects,the financial condition and result of operations of the Company.

Dated:  November 8, 2006

|        |   | By:    |   | /S/ THOMAS P. BENSON                                     |
|--------|--------|--------|--------|----------------------------------------------------------|
|   |   |   |   | Thomas P. Benson                                         |
|   |   |   |   | *Chief Financial Officer, Executive Vice President  and* |
|   |   |   |   | *Treasurer (Principal Financial Officer)*                |

 

This certification accompanies this Report on Form 10-Qpursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not,except to the extent required by such Act, be deemed filed by the Company forpurposes of Section 18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement requiredby Section 906, or other document authenticating, acknowledging, orotherwise adopting the signature that appears in typed form with the electronicversion of this written statement required by Section 906, has beenprovided to the Company and will be retained by the Company and furnished tothe Securities and Exchange Commission or its staff upon request.

----
Exhibit 35.1

AMERICAN HONDA FINANCE CORPORATION

ANNUAL COMPLIANCE CERTIFICATE

PURSUANT TO SECTION 3.11(a) OF THE

SALE AND SERVICING AGREEMENT AND

ITEM 1123 OF REGULATION AB

I, Paul C. Honda, do hereby certify that I am the Vice President and Assistant Secretary of American Honda Finance Corporation, a California corporation (the “Company”), and further certify on behalf of the Company in its capacity as servicer (the “Servicer” and “Sponsor”) under the Sale and Servicing Agreement (the “Agreement”) dated as of May 26, 2021 among the Servicer and Sponsor, American Honda Receivables LLC, as Seller, and Honda Auto Receivables 2021-2 Owner Trust, as follows:

(i) A review of the activities of the Servicer during the reporting period ended March 31, 2022, and of its performance under the Agreement has been made under my supervision.


(ii) To the best of my knowledge, based on such review, the Servicer has fulfilled all of its obligations under the Agreement throughout such period in all material respects.


IN WITNESS WHEREOF, I have hereunto set my hand this 16th day of May, 2022.



| |                                                     
| | ----------------------------------------------------
| | /s/ Paul C. Honda                                   
| | Paul C. Honda                                       
| | Vice President and Assistant Secretary              
| | (senior officer in charge of the servicing function)







---
PUBLIC LAW 107–164—APR. 18, 2002 116 STAT. 127

LEGISLATIVE HISTORY—H.R. 2876:

CONGRESSIONAL RECORD:

Vol. 147 (2001): Oct. 16, considered and passed House.

Vol. 148 (2002): Mar. 22, considered and passed Senate.

Æ

Public Law 107–164

107th Congress

An Act

To designate the facility of the United States Postal Service located in Harlem,

Montana, as the ‘‘Francis Bardanouve United States Post Office Building’’.

Be it enacted by the Senate and House of Representatives of

the United States of America in Congress assembled,

SECTION 1. DESIGNATION.

The facility of the United States Postal Service located at

216 2nd Street, S.W. in Harlem, Montana, shall be designated

and known as the ‘‘Francis Bardanouve United States Post Office

Building’’.

SEC. 2. REFERENCES.

Any reference in a law, map, regulation, document, paper,

or other record of the United States to the United State Post

Office referred to in section 1 shall be deemed to be a reference

to the ‘‘Francis Bardanouve United States Post Office Building’’.

Approved April 18, 2002.

Apr. 18, 2002

[H.R. 2876]
Cherry

not so presented need not be addressed by this court."). Accordingly, we

ORDER the judgment of conviction AFFIRMED. 2

Hardesty cit. ‘

, J. Douglas

cc: Hon. Douglas Smith, District Judge Spencer M. Judd Attorney General/Carson City Clark County District Attorney Eighth District Court Clerk

2 The fast track statement does not comply with the Nevada Rules ofAppellate Procedure because the text in the body of the brief is not doublespaced, see NRAP 3C(h)(1); NRAP 32(a)(4), and the fact section does not contain any citations to the record, see NRAP 3C(e)(1)(C) and NRAP 28(e)(1). Counsel for Vazquez is cautioned that the failure to comply with the briefing requirements in the future may result in the imposition of sanctions. See NRAP 3C(n).

SUPREME COURT

OF NEVADA 2
(0) 1947A em.
§ 61.40 Special need grants—general. ( a ) VA provides special need grants to public or nonprofit private entities that will create or provide supportive housing and services, which they would not otherwise create or provide, for the following special need homeless veteran populations: ( 1 ) Women;
( 2 ) Frail elderly;
( 3 ) Terminally ill;
( 4 ) Chronically mentally ill; or
( 5 ) Individuals who have care of minor dependents.
( b ) Applicants must submit an application package for a capital or non-capital grant, which will be processed by the VA National GPD Program in accordance with this part; however, to be eligible for a capital special need grant, an applicant must receive at least 800 points (out of a possible 1000) and must receive points under each of the following paragraphs: (b), (c), (d), (e), (f), and (g) of § 61.13. Non-capital special need grants are rated in the same manner as non-capital grant applications under § 61.32.
( c ) A recipient of a grant under paragraph (a) of this section may use amounts under the grant to provide services directly to a dependent of a homeless veteran with special needs who is under the care of such homeless veteran while such homeless veteran receives services from the grant recipient under this section.
( d ) The following sections apply to special need grants: §§ 61.61 through 61.67, § 61.80, and § 61.82.
(Authority: 38 U.S.C. 501, 2061)
#### § 21.4007 Forfeiture.

The rights of a veteran or eligible person to receive educational assistance allowance or special training allowance are subject to forfeiture under the provisions of §§ 3.900, 3.901 (except paragraph (c)), 3.902 (except paragraph (c)), 3.903, 3.904, 3.905 and 19.2 of this chapter.

(Authority: 38 U.S.C. 6103, 6104 and 6105)

[54 FR 4286, Jan. 30, 1989]
### SAT Report PMN Number: P-13-0201 SAT Date: 1/18/2013 Print Date: 4/1/2013

Related cases :

Concern levels : Type of Concern: Health Eco Comments Level of Concern: 2 3

Persistence Bioaccum Toxicity Comments 2 11

Exposure Based Review : Health: N o Ecotox: Yes
Routes of exposure : Health: Dermal Inhalation Ecotox: All releases to water Fate: ; Keywords : Keywords: IRR/CORROSION, LUNG, UNCERT-SENS-DERMAL/RESPIRATORY, AQUATOX-A,C
Summary of Assessment :

Fate : Fate Summary: P-13-0200-09 FATE: Estimations for Liquid with MP < 25 C (E) log Kow = 5.01 (E) S = Disp. / 1.38 mg /L at 25 C (ICB / E) VP < 1.0E-6 torr at 25 C (E) BP > 400 C (E) H < 1.00E-8 (E) log Koc = 5.86 (E)log Fish BCF = 1.85 (E) log Fish BAF = 1.82 (E) POTW removal (%) = 75-90 via sorption and biodeg Time for complete ultimate aerobic biodeg = wk-mo Sorption to soils/sediments = strong PBT Potential: P2B1 *CEB FATE: Migration to ground water = slow

Health : Health Summary: Absorption is poor through the skin, moderate through the GI tract, and good through the lungs based on analogs. There is concern for irritation and p ossible corrosion based on the and concern for lung effects if respirable particles are inhaled based on cationic binding to lung tissues and the surfactant properties of the PMN material. There is also uncertain concern for dermal and respiratory sensitization based on smaller . Moderate concern.

Ecotox :
Test Organism Test Type Test End Point Predicted Measured Comments

fish 96-h LC50 2.9 daphnid 48-h LC50 0.46 green algal 96-h EC50 0.22 fish

_ chronic value 0.073 daphnid

_ chronic value 0.050

algal

_ chronic value 0.089
Sewage Sludge 3-h EC50

_ Sewage Sludge

_ Chronic Value _

Ecotox Values Comments: Predictions are based on SARs for ; SAR chemical class = liquid; log Kow = 4.42 (EPI); S = dispersible in water at 25 C (P); p H7; effective concentrations based on 100% active ingredients and mean measured concentrations; hardness < 150.0 mg/L as CaCO3; and TOC <2.0 mg/L;

Factors Values Comments Assessment Factor 10 Concentration of Concern ( p pb) 5

SARs iincludes molecular weight adjustment SAR Class Ecotox CategoryEcotox Factors Comments:

SAT Chair: Becky Jones
§ 80.4 Notice of Funding Opportunity (NOFO). When funds are available for VSTAGP grants, VA will publish a NOFO at *Grants.gov* (*https://www.grants.gov*). The NOFO will identify: ( a ) The location for obtaining VSTAGP grant applications, including the specific forms that will be required;
( b ) The date, time, and place for submitting completed VSTAGP grant applications;
( c ) Priority population categories;
( d ) The estimated total amount of funds available and the maximum funds available to a single grantee;
( e ) Matching funds requirements;
( f ) The minimum number of total points and points per category that an applicant must receive to be considered for a grant and information regarding the scoring process;
( g ) Any timeframes and manner for payments under the VSTAGP grant;
( h ) A description of eligible entities or other eligibility requirements necessary to receive the grant; and
( i ) Other information necessary for the VSTAGP grant application process, as determined by VA, including contact information for the office that will oversee the VSTAGP within VA.
(Authority: Pub. L. 116-315, sec. 4304; 2 CFR 200.203)
**UN PUBLISHED** 
UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

**No. 12**  **- 7750** 

UNITED STATES OF AMERICA , Plaintiff

– Appellee ,
v. TORREY DEVON WILLIAMS , Defendant

- Appellant
.

Appeal from the United States District Court for the Eastern District of North Carolina , at Raleigh
. W. Earl Britt, Senior District Judge. ( 5:10

- cr - 00178

- BR

- 1; 5:12

- cv - 00437

- BR )

Submitted : March 26, 2013 Decided: March 28, 2013

Before DUNCAN, FLOYD, and THACKER , Circuit Judges.

Dismissed by un published per curiam opinion
. Torrey Devon Williams, Appellant Pro S e . Jennifer P. May

- Parker, Assistant United States Attorney, Raleigh, North Carolina, for Appellee.
Unpublished opinions are not binding precedent in this circuit.2 PER CURIAM: Torrey Devon Williams seeks to appeal the district court’s order denying relief on his 28 U.S.C. A. § 2255 ( West Supp. 2012 ) motion. The order is not appealable unless a circuit justice or judge issues a cer tificate of appealability. 28 U.S.C. § 2253(c)(1) (B) (200 6 ). A certificate of appealability will not issue absent “a substantial showing of the denial of a constitutional right.” 28 U.S.C. § 2253(c)(2) (200 6 ). When the district court denies relief on t he merits, a prisoner satisfies this standard by demonstrating that reasonable jurists would find that the district court’s assessment of the constitutional claims is debatable or wrong. Slack v. McDaniel , 529 U.S. 473, 484 (2000); see Miller

- El v. Cockre ll , 537 U.S. 322, 336

- 38 (2003). When the district court denies relief on procedural grounds, the prisoner must demonstrate both that the dispositive procedural ruling is debatable, and that the motion states a debatable claim of the denial of a constitut ional right. Slack , 529 U.S. at 484

- 85. We have independently reviewed the record and conclude that Williams has not made the requisite showing. Accordingly, we deny a certificate of appealability and dismiss the appeal. We dispense with oral argument because the facts and legal3 contentions are adequately presented in the materials before th is court and argument would not aid the decisional process.

DISMISSED
EXHIBIT 32.1

                            CERTIFICATION PURSUANT TO
                               18 U.S.C. SS.1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly  Report of IR BioSciences  Holdings,  Inc. (the
"Company")  on Form  10-QSB for the three  months  ended March 31, 2006 as filed
with the Securities and Exchange  Commission on the date hereof (the  "Report"),
I, Michael K. Wilhelm, Chief Executive Officer of the Company, certify, pursuant
to 18 U.S.C.  ss.1350,  as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:

1. The Report fully complies with the  requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

2. The  information  contained in the Report  fairly  presents,  in all material
respects, the financial condition and results of operations of the Company.

                             /s/ Michael K. Wilhelm
                              -----------------------
                             Chief Executive Officer
                                  May 5, 2006

A signed  original of this written  statement  required by Section 906, an other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the  electronic  version of this written  statement
required by Section  906,  has been  provided to Company and will be retained by
the Company and furnished to the Securities and Exchange Commission or its staff
upon request.
<TABLE> <S> <C>


<ARTICLE> 7
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                              DEC-31-1996
<PERIOD-START>                                 JAN-01-1996
<PERIOD-END>                                   SEP-30-1996
<DEBT-HELD-FOR-SALE>                           209,410,554
<DEBT-CARRYING-VALUE>                                    0
<DEBT-MARKET-VALUE>                                      0
<EQUITIES>                                       8,759,444
<MORTGAGE>                                               0
<REAL-ESTATE>                                            0
<TOTAL-INVEST>                                 232,891,912
<CASH>                                             823,476
<RECOVER-REINSURE>                               6,861,469
<DEFERRED-ACQUISITION>                           3,571,428
<TOTAL-ASSETS>                                 441,161,263
<POLICY-LOSSES>                                263,966,615
<UNEARNED-PREMIUMS>                             32,247,734
<POLICY-OTHER>                                           0
<POLICY-HOLDER-FUNDS>                                    0
<NOTES-PAYABLE>                                 17,942,034
<PREFERRED-MANDATORY>                                    0
<PREFERRED>                                              0
<COMMON>                                           822,003
<OTHER-SE>                                     109,727,927
<TOTAL-LIABILITY-AND-EQUITY>                   441,161,263
<PREMIUMS>                                      57,252,479
<INVESTMENT-INCOME>                             10,368,896
<INVESTMENT-GAINS>                                 376,641
<OTHER-INCOME>                                   8,787,619
<BENEFITS>                                      35,779,841
<UNDERWRITING-AMORTIZATION>                      8,354,993
<UNDERWRITING-OTHER>                            14,334,338
<INCOME-PRETAX>                                 16,877,968
<INCOME-TAX>                                     3,616,872
<INCOME-CONTINUING>                             13,261,097
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                    13,261,097
<EPS-PRIMARY>                                         1.60
<EPS-DILUTED>                                         1.60
<RESERVE-OPEN>                                           0
<PROVISION-CURRENT>                                      0
<PROVISION-PRIOR>                                        0
<PAYMENTS-CURRENT>                                       0
<PAYMENTS-PRIOR>                                         0
<RESERVE-CLOSE>                                          0
<CUMULATIVE-DEFICIENCY>                                  0
        



</TABLE>